Canada markets closed

Savara Inc. (SVRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.9800+0.1300 (+2.68%)
At close: 04:00PM EDT
4.9800 0.00 (0.00%)
After hours: 06:14PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close4.8500
Open4.8800
Bid4.9400 x 200
Ask5.0300 x 100
Day's Range4.8450 - 4.9900
52 Week Range1.6300 - 5.7000
Volume904,198
Avg. Volume818,386
Market Cap687.977M
Beta (5Y Monthly)0.77
PE Ratio (TTM)N/A
EPS (TTM)-0.3300
Earnings DateMay 13, 2024 - May 17, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.79
  • Business Wire

    Savara Announces New Employment Inducement Grant

    AUSTIN, Texas, March 22, 2024--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees.

  • Business Wire

    Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update

    LANGHORNE, Pa., March 07, 2024--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the fourth quarter and full year ending December 31, 2023 and provided a business update.

  • Business Wire

    Savara to Present at the Barclays 26th Annual Global Healthcare Conference

    LANGHORNE, Pa., March 06, 2024--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on March 14, 2024 at 5:00am PT/8:00am ET. A live webcast of the fireside chat will be available on Savara’s website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days.